Both in Pharmaceuticals
Spyre Therapeutics vs Praxis Precision Medicines
Over the past year SYRE returned +317.5% and PRAX returned +54.1%; their daily moves had a correlation of 0.33.
SYRE +317.5% PRAX +54.1%Growth of $1, one year, split-adjusted
| Metric | SYRE | PRAX |
|---|---|---|
| Price | $99.27 | $280.51 |
| Market cap | $9.28B | $7.83B |
| Today | +3.94% | +2.38% |
| 1 month | +7.1% | −1.1% |
| 6 months | +39.8% | −15.8% |
| Year to date | +203.0% | −4.8% |
| 1 year | +305.8% | +41.1% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $1.15B | $758.6M |
| Dividend yield | — | — |
| Volatility (60d) | 59.2% | 48.5% |
| Short % of float | 15.6% | 14.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).